Section of Clinical Medicine and Ageing
The Section of Clinical Medicine and Ageing is part of the School of Bioscience and Medicine; which in turn is part of the Faculty of Health and Medical Sciences. This Section will become the research home for clinical academics at the University, other than those who sit in the Oncology Section or within the Clinical Research Centre.
The Section will support the Faculty research theme of ageing, as well as be a home for high quality research across the medical specialties. Research areas will range from population surveillance, through to vaccine effectiveness, child safeguarding, ophthalmology research, diabetes, cardiology, hepatology and audiology. The section will include basic scientists working on DNA damage and repair. We aim to explore opportunities for conducting translational studies with our colleagues in Biosciences and linking with other researchers across the University, in addition to our National and International collaborators. Additionally, we will be pursuing opportunities to bring relevant disease registers to the University as they have scope to underpin high quality research.
The section will be the home to the primary care (chair Simon de Lusignan) and diabetes (chair Martin Whyte) Surrey Health Partners clinical academic groups. It will also host the data and analysis hub of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) and the Type 2 Diabetes Real World Evidence Centre, set up as a collaboration with Lilly. The section is the home to the Clinical Informatics & Health Outcomes Research Group - www.clininf.eu.
The first drafts of our mission and vision statements are shown below. These will be developed through strategy meetings and through meetings with our Advisory group.
To improve human health through world leading discovery, research and learning
To provide societal benefits through the optimisation of health with priority given to methods and interventions that address current global health challenges including an ageing population with multimorbidity. We provide this through excellence in research, enterprise and scholarship. Our approach recognises the competitiveness of the research and teaching environment. We will work adopting the best from lean and agile management; but within a strongly personally supportive research and teaching environment.
A 4-arm randomised controlled trial (RCT) to test two types of GP referral intervention that were intended to increase physical and sporting activity among currently inactive 18-74 year old people with hypertension, suspected hypertension,
Predicting Falls and When to Intervene in Older People: A Multilevel Logistical Regression Model and Cost Analysis
Falls are the leading cause of injury in older people. Reducing falls could reduce financial pressures on health services. We carried out this research to develop a falls risk model, using routine primary care and hospital data to identify those at risk of falls, and apply a cost analysis to enable commissioners of health services to identify those in whom savings can be made through referral to a falls prevention service.